Publication of a Shareholders Letter, January 2015

Onxeo S.A. (Euronext Paris, NASDAQ OMX Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announces the publication of s Shareholders Letter.

For this new year, Onxeo publishes a Shareholders Letter to update on major achievements of 2014 and announce the steps of the coming months.

150128EN_Shareholders Letter